Special Invitation: IEEE MTT-S Chapter Technical Webinar
ABV-Indian Institute of Information Technology and Management, Gwalior
Nanotechnology & Translational Skin Therapeutics
CH11187

Nanoparticles Advancement in Surface Skin Therapy

Explore cutting-edge advances in nanoparticle-enabled topical and transdermal therapies: formulation strategies, surface functionalization, penetration mechanisms, controlled release and clinical translation.

29th November 2025
6:30 PM IST (GMT+5:30)
00 Days
00 Hours
00 Minutes
00 Seconds
Register Now - Free

About This Webinar

This technical webinar focuses on scientific and translational aspects of nanoparticle-based surface skin therapy. Topics include nanoparticle design (lipid, polymeric, inorganic), strategies to enhance dermal penetration, safety and toxicity evaluation, controlled-release systems, and clinical implications for dermatology and cosmetology.

🧪

Design & Formulation

Cerium oxide nanoparticles (CNPs) are engineered by controlling particle size, surface charge, and Ce³⁺/Ce⁴⁺ oxidation balance to optimize biological compatibility.Surface functionalization with biopolymers or ligands enhances stability in biological fluids and improves interaction with skin layers.

🔬

Characterization & Penetration

Characterization tools like TEM, DLS, XRD, FTIR, and zeta potential analysis determine nanoparticle size, structure, and surface properties.CNP penetration depends heavily on size, charge, and agglomeration behavior, influencing their ability to cross skin barriers.

🩺

Safety & Clinical Translation

Safety assessment focuses on evaluating oxidative stress, membrane integrity, and long-term bio compatibility of CNPs.While their antioxidant properties help reduce inflammation, improper size or charge can still cause cytotoxic effects.

Research Publications

This webinar highlights key advancements in AI-powered cyber defense, mathematical modelling of cyber risks, and simulation-driven analysis used to predict, prevent, and mitigate complex cyber threats across modern digital environments.

Edition Smart Agriculture for Sustainable Practices The Role of AI, IoT, and Machine Learning Edited By S. N. Kumar, Sherin Zafar, Arun S, Sameena Naaz, M. M. Sufyan Beg, Eduard Babulak Copyright 2026, ISBN 9781032975016 376 Pages 66 B/W Illustrations

December 3, 2025 by Chapman & Hall, in press

Ashish Bagwari, Jorge Luis Victoria Barbosa, Eduard Babulak, Durg Singh Chauhan: "Emerging Wireless Technologies and Sciences"

Second International Conference, ICEWTS 2024, Uttarakhand, India, October 6–7, 2024, Proceedings, Part of the book series: Communications in Computer and Information Science (CCIS, volume 2399), Publisher Springer Cham, Softcover ISBN 978-3-031-87885-5, Series ISSN 1865-0929, Series E-ISSN 1865-0937, 26 April 2025, published.

Eduard Babulak: "Advances in Digital Transformation - Rise of Ultra-Smart Fully Automated Cyberspace"

published on July 17th 2024, IntechOpen, London, UK

S. N. Kumar, Sherin Zafar, Eduard Babulak, M. Afshar Alam, Farheen Siddiqui, "Artificial Intelligence in Telemedicine: Processing of Biosignals and Medical images",529949- IMVRA Series, 1st edition

published in August 2023

Eduard Babulak, "Chatbots - The AI-driven Customer Front-line Services"

published September 13th, 2023

Key Technology Domains

Interaction
Cellular Uptake & Nano–Bio Interface
Dynamics
Imaging & Assays
Safety
Toxicology
Redox Activity
Antioxidant Mechanisms & ROS Modulation
Therapeutics
Wound Healing & Regenerative Applications

Featured Speaker

Dr. Sushant Singh
Dr. Sushant Singh

Department of Life Sciences

School of Bio Science and Technology (SSBT)

Sharda University, Greater Noida, U.P (INDIA)

Prof. Sushant Singh is a Professor in the Department of Life Sciences at Sharda School of Bio Science and Technology (SSBT), Sharda University. He is a nanobiotechnology researcher with extensive expertise in nano–bio interactions, nanoparticle therapeutics, and biomedical applications.

He completed his PhD in Biotechnology from IIT Guwahati and carried out prestigious postdoctoral research at the University of Central Florida, Ohio State University, and Sanford Burnham Prebys Medical Discovery Institute (USA).

With 11 patents, 50+ research publications, and major funded projects from DST-SERB, MSME, and Sharda University, Prof. Singh is a leading voice in nanomedicine and cellular nanotechnology—making his insights highly valuable for our webinar on nanoparticle-based skin therapy and cerium oxide nano–bio interactions.

Nanomedicine
Dermal Delivery
Clinical Translation
Toxicology
11+
Years Research
50+
Publications
2
Projects
14
Patents / Clinical Studies

Research Expertise

Areas of focus: Nanoparticle engineering and nano–bio interface interactions,Size-dependent cellular uptake and redox-active cerium oxide nanoparticles,Topical and transdermal nano-delivery systems for skin therapy,Oxidative stress modulation, anti-inflammatory nanotherapeutics, and safety/toxicology assessments

Webinar Curriculum

A focused program covering scientific foundations, formulation practice, characterization, safety, and translational case studies relevant to nanoparticle-enabled skin therapies.

Introduction to Cerium Oxide Nanoparticles in Skin Therapy

Overview of cerium oxide nanoparticles (CeO₂ NPs) and their unique redox-driven antioxidant behavior (Ce³⁺/Ce⁴⁺).

Nano–Bio Interface & Targeted Interaction

Focus on how CeO₂ nanoparticles interact with biomolecules at the nano–bio interface, including proteins, lipids, and extracellular matrices.

Design, Size Engineering & Controlled Uptake

Principles of designing CNPs with controlled particle size, morphology, and Ce³⁺/Ce⁴⁺ ratio for targeted biological behavior.

Characterization & Cellular Penetration Studies

Analytical techniques (TEM, DLS, XRD, FTIR, zeta potential) to evaluate CNP structure, size, surface chemistry, and stability.

Safety, Biocompatibility & Toxicological Response

Evaluation of oxidative stress modulation, cytotoxicity, membrane integrity, and inflammatory response associated with CeO₂ nanoparticles.

Future Directions in Nanomedicine & Artificial-Cell Technologies

Emerging concepts such as artificial-cell-inspired nanosystems for enhanced skin therapy. Advances in designing smart, responsive CeO₂ nanoparticle platforms with adaptive redox regulation.

Future Directions

Emerging trends: theranostic nanoparticles, AI-assisted formulation design, personalized topical therapeutics, and green manufacturing for scalable production.

Frequently Asked Questions

Who should attend this webinar?
Researchers, formulation scientists, dermatologists, product developers in cosmeceuticals and pharma, postgraduate students, and regulatory professionals interested in nanoparticle therapeutics for skin.
Will the webinar include experimental data?
No. The webinar will Not present experimental data.
Is the webinar suitable for clinicians?
Yes. Translational discussions and clinical case studies will be included to help clinicians understand applications and safety considerations of nanoparticle-based therapies.
Will participants receive materials and certificates?
Yes. Registered participants will receive presentation slides and a Participation Certificate after the webinar.
How do I join the webinar?
The event is virtual on Zoom. Registered attendees will receive the Zoom link and joining instructions via email before the session.
Is registration free?
Yes — registration is free. Spaces are limited; please register early to secure your seat.

Register for Free

Register now to receive the Zoom link and participation certificate.

    Participation Certificate will be provided to attendees.

    Reserve Your Spot Today

    Limited seats available. Register to learn from an expert in nanoparticle therapeutics and dermal delivery.

    Register Now

    Supporting UN Sustainable Development Goals

    This research contributes to health, innovation, and responsible production by enabling safer and more effective topical therapies and greener nanoparticle manufacturing.

    Primary Focus

    SDG 3: Good Health and Well-Being

    Key Target:
    Ensure access to safe, effective, and innovative healthcare solutions

    Nanoparticle-based skin therapies enhance topical drug delivery, transdermal penetration, and localized treatment of dermatological conditions. By improving bioavailability and reducing systemic side effects, these nanosystems support better patient outcomes, faster healing, and more targeted therapies for skin infections, inflammation, wounds, and cosmetic dermatology.

    SDG 9: Industry, Innovation and Infrastructure

    Key Target:
    Strengthen scientific research and foster innovation in healthcare technologies.

    Advancements in nanoparticle-enabled skin therapy—such as surface functionalization, controlled release systems, nanoemulsions, lipid nanoparticles, and follicle-targeting carriers—drive innovation in pharmaceutical and cosmetic industries. These technologies promote the development of next-generation dermal formulations, strengthening research capacity, industrial upskilling, and high-tech healthcare infrastructure.

    SDG 12: Responsible Consumption & Production

    Key Target:
    Encourage sustainable production practices and minimize environmental impact.

    Green synthesis methods for skin-therapy nanoparticles, biodegradable nanocarriers, and energy-efficient formulation processes help reduce environmental impact. Eco-friendly nanoparticle production ensures safer residues, less chemical waste, and more sustainable manufacturing of dermatological and cosmetic products.

    How This Research Contributes to Global Goals

    Health Impact

    Improved delivery systems enable targeted treatments, reducing side effects and increasing therapeutic efficacy for skin conditions.

    Innovation

    Novel nanoparticle platforms and characterization tools accelerate translational research and product development.

    Sustainable Production

    Adoption of green chemistry and energy-efficient processing supports sustainable manufacturing pathways.